Phenotypic and Genotypic Spectrum of Early-Onset Developmental and Epileptic Encephalopathies—Data from a Romanian Cohort
Tóm tắt
Từ khóa
Tài liệu tham khảo
Symonds, 2021, Early childhood epilepsies: Epidemiology, classification, aetiology, and socio-economic determinants, Brain, 144, 2879, 10.1093/brain/awab162
Newton, 2012, Epilepsy in poor regions of the world, Lancet, 380, 1193, 10.1016/S0140-6736(12)61381-6
Berg, 2008, Global cognitive function in children with epilepsy: A community-based study, Epilepsia, 49, 608, 10.1111/j.1528-1167.2007.01461.x
Wirrell, 2012, Predictors and course of medically intractable epilepsy in young children presenting before 36 months of age: A retrospective, population-based study, Epilepsia, 53, 1563, 10.1111/j.1528-1167.2012.03562.x
Moseley, 2013, Early onset epilepsy is associated with increased mortality: A population-based study, Epilepsy Res., 105, 410, 10.1016/j.eplepsyres.2013.03.002
Berg, 2012, Age at onset of epilepsy, pharmacoresistance, and cognitive outcomes: A prospective cohort study, Neurology, 79, 1384, 10.1212/WNL.0b013e31826c1b55
Wirrell, 2022, Methodology for Classification and Definition of Epilepsy Syndromes: Report of the ILAE Task Force on Nosology and Definitions, Epilepsia, 63, 1333, 10.1111/epi.17237
Howell, 2021, The severe epilepsy syndromes of infancy: A population-based study, Epilepsia, 62, 358, 10.1111/epi.16810
Eltze, 2013, A population-based study of newly diagnosed epilepsy in infants, Epilepsia, 54, 437, 10.1111/epi.12046
Borlot, 2021, Early-Onset Developmental and Epileptic Encephalopathies of Infancy: An Overview of the Genetic Basis and Clinical Features, Pediatr. Neurol., 116, 85, 10.1016/j.pediatrneurol.2020.12.001
Ko, 2018, Targeted gene panel and genotype-phenotype correlation in children with developmental and epileptic encephalopathy, Epilepsy Res., 141, 48, 10.1016/j.eplepsyres.2018.02.003
Carapancea, 2020, An Atypical Case of Cluster Convulsions with Gastroenteritis in a child harboring a likely benign heterozygous variant of the NTRK2 gene, Rom. Biotechnol. Lett., 25, 2127, 10.25083/rbl/25.6/2127.2131
Roza, 2020, A 14q31.1–q32.11 deletion case: Genotype—neurological phenotype correlations in 14q interstitial deletion syndrome, Rom. Biotechnol. Lett., 25, 1677, 10.25083/rbl/25.3/1677.1682
Wirrell, 2011, Incidence and classification of new-onset epilepsy and epilepsy syndromes in children in Olmsted County, Minnesota from 1980 to 2004: A population-based study, Epilepsy Res., 95, 110, 10.1016/j.eplepsyres.2011.03.009
Scheffer, 2020, Deciphering the concepts behind “Epileptic encephalopathy” and “Developmental and epileptic encephalopathy”, Eur. J. Paediatr. Neurol., 24, 11, 10.1016/j.ejpn.2019.12.023
Kalser, 2018, The epileptic encephalopathy jungle–from Dr West to the concepts of aetiology-related and developmental encephalopathies, Curr. Opin. Neurol., 31, 216, 10.1097/WCO.0000000000000535
McLaren, 2016, The Ensembl Variant Effect Predictor, Genome Biol., 17, 122, 10.1186/s13059-016-0974-4
Liu, 2020, dbNSFP v4: A comprehensive database of transcript-specific functional predictions and annotations for human nonsynonymous and splice-site SNVs, Genome Med., 12, 103, 10.1186/s13073-020-00803-9
Kopanos, 2018, VarSome: The human genomic variant search engine, Bioinformatics, 35, 1978, 10.1093/bioinformatics/bty897
Landrum, 2020, ClinVar: Improvements to accessing data, Nucleic Acids Res., 48, D835, 10.1093/nar/gkz972
Online Mendelian Inheritance in Man, OMIM® (2022, May 01). McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD) World Wide Web URL. Available online: https://omim.org/.
Richards, 2015, Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology, Genet. Med., 17, 405, 10.1038/gim.2015.30
Shi, 2012, Mosaic SCN1A mutations in familial partial epilepsy with antecedent febrile seizures, Genes Brain Behav., 11, 170, 10.1111/j.1601-183X.2011.00756.x
Depienne, 2010, Mechanisms for variable expressivity of inherited SCN1A mutations causing Dravet syndrome, J. Med Genet., 47, 404, 10.1136/jmg.2009.074328
Xu, 2015, Amplicon Resequencing Identified Parental Mosaicism for Approximately 10% of “de novo” SCN1A Mutations in Children with Dravet Syndrome, Hum. Mutat., 36, 861, 10.1002/humu.22819
Catarino, 2011, Dravet syndrome as epileptic encephalopathy: Evidence from long-term course and neuropathology, Brain, 134, 2982, 10.1093/brain/awr129
Wallace, 2003, Sodium channel 1-subunit mutations in severe myoclonic epilepsy of infancy and infantile spasms, Neurology, 61, 765, 10.1212/01.WNL.0000086379.71183.78
Claes, 2001, De Novo Mutations in the Sodium-Channel Gene SCN1A Cause Severe Myoclonic Epilepsy of Infancy, Am. J. Hum. Genet., 68, 1327, 10.1086/320609
Mulley, 2013, Role of the sodium channelSCN9A in genetic epilepsy with febrile seizures plus and Dravet syndrome, Epilepsia, 54, e122, 10.1111/epi.12323
Arsov, 2012, Glucose transporter 1 deficiency in the idiopathic generalized epilepsies, Ann. Neurol., 72, 807, 10.1002/ana.23702
Holland, 2011, When should clinicians order genetic testing for Dravet syndrome?, Pediatric Neurol., 45, 319, 10.1016/j.pediatrneurol.2011.08.001
Perucca, 2019, Identifying mutations in epilepsy genes: Impact on treatment selection, Epilepsy Res., 152, 18, 10.1016/j.eplepsyres.2019.03.001
Parrini, 2016, Diagnostic Targeted Resequencing in 349 Patients with Drug-Resistant Pediatric Epilepsies Identifies Causative Mutations in 30 Different Genes, Hum. Mutat., 38, 216, 10.1002/humu.23149
Liu, 2018, Novel and de novo mutations in pediatric refractory epilepsy, Mol. Brain, 11, 48, 10.1186/s13041-018-0392-5
Jiang, 2018, Clinical and molecular analysis of epilepsy-related genes in patients with Dravet syndrome, Medicine, 97, e13565, 10.1097/MD.0000000000013565
Bender, 2012, SCN1A mutations in Dravet syndrome: Impact of interneuron dysfunction on neural networks and cognitive outcome, Epilepsy Behav., 23, 177, 10.1016/j.yebeh.2011.11.022
Parihar, 2013, The SCN1A gene variants and epileptic encephalopathies, J. Hum. Genet., 58, 573, 10.1038/jhg.2013.77
Weuring, 2019, Influence of common SCN1A promoter variants on the severity of SCN1A-related phenotypes, Mol. Genet. Genom. Med., 7, e00727, 10.1002/mgg3.727
Guerrini, 2010, Variable epilepsy phenotypes associated with a familial intragenic deletion of the SCN1A gene, Epilepsia, 51, 2474, 10.1111/j.1528-1167.2010.02790.x
Suls, 2010, Four generations of epilepsy caused by an inherited microdeletion of the SCN1A gene, Neurology, 75, 72, 10.1212/WNL.0b013e3181e62088
Kanai, 2004, Effect of localization of missense mutations in SCN1A on epilepsy phenotype severity, Neurology, 63, 329, 10.1212/01.WNL.0000129829.31179.5B
Stosser, 2018, High frequency of mosaic pathogenic variants in genes causing epilepsy-related neurodevelopmental disorders, Genet. Med., 20, 403, 10.1038/gim.2017.114
Nakayama, 2018, Somatic mosaic deletions involving SCN1A cause Dravet syndrome, Am. J. Med Genet. Part A, 176, 657, 10.1002/ajmg.a.38596
Kwong, A.K.-Y., Fung, C.-W., Chan, S.-Y., and Wong, V.C.-N. (2012). Identification of SCN1A and PCDH19 Mutations in Chinese Children with Dravet Syndrome. PLoS ONE, 7.
Kang, 2016, Molecular Pathogenic Basis for GABRG2 Mutations Associated With a Spectrum of Epilepsy Syndromes, From Generalized Absence Epilepsy to Dravet Syndrome, JAMA Neurol., 73, 1009, 10.1001/jamaneurol.2016.0449
Gontika, 2017, Novel SCN1A and GABRA1 Gene Mutations with Diverse Phenotypic Features and the Question on the Existence of a Broader Spectrum of Dravet Syndrome, Child Neurol. Open, 4, 2329048x17706794, 10.1177/2329048X17706794
Depienne, C., Bouteiller, D., Keren, B., Cheuret, E., Poirier, K., Trouillard, O., Benyahia, B., Quelin, C., Carpentier, W., and Julia, S. (2009). Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females. PLoS Genet., 5.
Wolff, 2017, Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders, Brain, 140, 1316, 10.1093/brain/awx054
Wolff, 2019, Phenotypic spectrum and genetics of SCN2A-related disorders, treatment options, and outcomes in epilepsy and beyond, Epilepsia, 60, S59, 10.1111/epi.14935
Howell, 2015, SCN2A encephalopathy: A major cause of epilepsy of infancy with migrating focal seizures, Neurology, 85, 958, 10.1212/WNL.0000000000001926
Singh, N.A., Pappas, C., Dahle, E.J., Claes, L.R.F., Pruess, T.H., De Jonghe, P., Thompson, J., Dixon, M., Gurnett, C.A., and Peiffer, A. (2009). A Role of SCN9A in Human Epilepsies, As a Cause of Febrile Seizures and As a Potential Modifier of Dravet Syndrome. PLoS Genet., 5.
Musumeci, 2020, A Family with a Complex Phenotype Caused by Two Different Rare Metabolic Disorders: GLUT1 and Very-Long-Chain Fatty Acid Dehydrogenase (VLCAD) Deficiencies, Front. Neurol., 11, 514, 10.3389/fneur.2020.00514
Kim, 2019, Diagnostic Challenges Associated with GLUT1 Deficiency: Phenotypic Variabilities and Evolving Clinical Features, Yonsei Med. J., 60, 1209, 10.3349/ymj.2019.60.12.1209
Leen, 2010, Glucose transporter-1 deficiency syndrome: The expanding clinical and genetic spectrum of a treatable disorder, Brain, 133, 655, 10.1093/brain/awp336
Ritter, D.M., and Holland, K. (2020). Genetic Testing in Epilepsy. Seminars in Neurology, Thieme Medical Publishers, Inc.
Balciuniene, 2019, Use of a Dynamic Genetic Testing Approach for Childhood-Onset Epilepsy, JAMA Netw. Open, 2, e192129, 10.1001/jamanetworkopen.2019.2129
Lal, D., Reinthaler, E.M., Dejanovic, B., May, P., Thiele, H., Lehesjoki, A.-E., Schwarz, G., Riesch, E., Ikram, M.A., and Van Duijn, C.M. (2016). Evaluation of Presumably Disease Causing SCN1A Variants in a Cohort of Common Epilepsy Syndromes. PLoS ONE, 11.
Weckhuysen, 2016, Pitfalls in genetic testing: The story of missed SCN1A mutations, Mol. Genet. Genom. Med., 4, 457, 10.1002/mgg3.217
Sahli, 2019, Clinical exome sequencing identifies two novel mutations of the SCN1A and SCN2A genes in Moroccan patients with epilepsy: A case series, J. Med Case Rep., 13, 1, 10.1186/s13256-019-2203-8
Lemke, 2012, Targeted next generation sequencing as a diagnostic tool in epileptic disorders, Epilepsia, 53, 1387, 10.1111/j.1528-1167.2012.03516.x
Carvill, 2014, GABRA1 and STXBP1: Novel genetic causes of Dravet syndrome, Neurology, 82, 1245, 10.1212/WNL.0000000000000291
Suls, 2013, De Novo Loss-of-Function Mutations in CHD2 Cause a Fever-Sensitive Myoclonic Epileptic Encephalopathy Sharing Features with Dravet Syndrome, Am. J. Hum. Genet., 93, 967, 10.1016/j.ajhg.2013.09.017
Costain, 2019, Clinical Application of Targeted Next-Generation Sequencing Panels and Whole Exome Sequencing in Childhood Epilepsy, Neuroscience, 418, 291, 10.1016/j.neuroscience.2019.08.016
Yang, 2018, Clinical and genetic spectrum of a large cohort of children with epilepsy in China, Genet. Med., 21, 564, 10.1038/s41436-018-0091-8
Poduri, 2017, When should genetic testing be performed in epilepsy patients?, Epilepsy Curr., 17, 16, 10.5698/1535-7511-17.1.16
Schouten, 2016, Clinical exome sequencing for cerebellar ataxia and spastic paraplegia uncovers novel gene–disease associations and unanticipated rare disorders, Eur. J. Hum. Genet., 24, 1460, 10.1038/ejhg.2016.42
Patel, 2015, Diagnostic yield of genetic testing in epileptic encephalopathy in childhood, Epilepsia, 56, 707, 10.1111/epi.12954
Zhou, 2018, Novel mutations and phenotypes of epilepsy-associated genes in epileptic encephalopathies, Genes Brain Behav., 17, e12456, 10.1111/gbb.12456
Takata, 2019, Comprehensive analysis of coding variants highlights genetic complexity in developmental and epileptic encephalopathy, Nat. Commun., 10, 2506, 10.1038/s41467-019-10482-9